Greenwich LifeSciences (GLSI) executive Thompson bought 250 shares for $3,849 at $15.40
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Jaye Thompson (executive at Greenwich LifeSciences Inc., GLSI) reported that they bought 250 shares for $3,849 at $15.40 on Feb 24, 2023. After these transactions the filing shows 257,495 shares held directly.
- Reporting person
- Thompson Jaye
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 24, 2023 | Open-market purchase (P) | Common Stock | +250 | $15.40 | $3,849 | 257,495 direct |
Holdings before and after
- Common Stock: 257,245 to 257,495 direct
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Thompson report in this GLSI Form 4?
Jaye Thompson (executive at Greenwich LifeSciences Inc., GLSI) reported that they bought 250 shares for $3,849 at $15.40 on Feb 24, 2023. After these transactions the filing shows 257,495 shares held directly.
How many GLSI shares does Thompson hold after this filing?
The filing shows 257,495 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for GLSI
Earlier insider filings at GLSI
- Feb 22, 2023SEC Form 4: Patel Snehal bought $9,918 worth of shares (600 units at $16.53), increasing direct ownership by 0.02% to 2,736,486 units
- Feb 14, 2023SEC Form 4: Patel Snehal bought $18,680 worth of shares (1,000 units at $18.68), increasing direct ownership by 0.04% to 2,735,886 units
- Feb 7, 2023SEC Form 4: Thompson Jaye bought $5,210 worth of shares (250 units at $20.84), increasing direct ownership by 0.10% to 257,245 units
- Jan 31, 2023SEC Form 4: Patel Snehal bought $38,700 worth of shares (2,000 units at $19.35), increasing direct ownership by 0.07% to 2,734,886 units
- Jan 30, 2023SEC Form 4: Thompson Jaye bought $4,800 worth of shares (250 units at $19.20), increasing direct ownership by 0.10% to 256,995 units
Quantisnow market dataNASDAQ
GLSI
Greenwich LifeSciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for GLSI
Full GLSI profile on Quantisnow Follow GLSI and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time